FCA Venture Partners
Overview
FCA Venture Partners is a venture capital firm investing in early-stage healthcare technology and technology-enabled healthcare services companies that improve patient care, reduce costs, or increase efficiency . FCA Venture Partners has a long history of investing in successful healthcare entrepreneurs . They are passionate about building sustainable businesses and providing strategic value to its portfolio companies .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SonderMind | Jul 2021 | Series C | Co-investor |
| Clinical Ink | Mar 2015 | VC Round | Co-investor |
| evolvedMD | Jul 2025 | Series B | Co-investor |
| Posterity Health | Feb 2025 | Series A | Co-investor |
| StudioNow | Aug 2014 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
John R. Burch
Managing Partner
Matthew A. King
Managing Partner
Andrew Bouldin
Partner
Nancy Allen
Partner Chief Financial Officer
Andy Lutz
Principal
Will Hawkins
Principal
John Orr
Investor
Whitney Kalb
Partner General Counsel
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is FCA Venture Partners based?
FCA Venture Partners is headquartered in Nashville, Tennessee, United States.
When was FCA Venture Partners founded?
FCA Venture Partners was founded in 1996.
How many portfolio companies does FCA Venture Partners have?
FCA Venture Partners has 39 portfolio companies in Caplight's dataset.
What are some companies in FCA Venture Partners's portfolio?
Portfolio companies visible on Caplight include SonderMind, Clinical Ink, evolvedMD, Posterity Health, StudioNow.
What was FCA Venture Partners's most recent investment shown here?
FCA Venture Partners's most recent investment in this portfolio sample was in evolvedMD in 2025.
What sectors does FCA Venture Partners focus on?
FCA Venture Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Media, Entertainment & Gaming, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Enterprise Software, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does FCA Venture Partners focus on?
FCA Venture Partners typically invests at the Early stage.
What is FCA Venture Partners's AUM?
FCA Venture Partners's assets under management are estimated between $100.0M and $250.0M.